As Per the Report, the Size of the Europe Muscle Stimulation Devices Market was valued at USD 146.85 Million in 2022 and is projected to reach USD 189.98 Million by 2027, growing at a CAGR of 5.29% during the forecast period 2022 to 2027.
The European muscle stimulation devices market is expected to be driven by the factors such as an increase in the prevalence of musculoskeletal disorders and the growing awareness about efficient treatment outcomes of electrical stimulation therapy.
Other factors such as improving healthcare infrastructure, favorable reimbursement policies, and increasing product approvals are uplifting the market growth.
The increasing cases of chronic pain and muscle injuries across the region, especially among older adults, boost the demand for the muscle stimulation devices market, however, due to growing engagement in sports and physical fitness activities. In addition, many sports enthusiasts are using muscle stimulation devices to help with warm-ups and rehabilitation in an accident.
Besides these factors, ongoing technological advances and product innovations will significantly grow the market.
These devices provide benefits such as non-evasive electrotherapy, mobility, and cost-benefit analysis, in addition to reduced pain and enhanced comfort; the market is rising due to these factors.
Muscle stimulators promote strength by flexing and exercising, weakening muscle tissue, and adapting to particular response patterns by improving blood circulation to the afflicted area and speeding up the healing process. As a result, the market prospects will be bolstered as these devices become more widely used.
Key market players are implementing various market strategies to gain a competitive advantage over the marketplace—the techniques such as partnerships, mergers, and acquisitions to expand the regional market growth.
However, the lack of skilled professional physiotherapists to help patients use these devices is hampering the market growth. In addition, there are limited established recommendations or usage indications for devices like electrical stimulators, galvanic stimulators, or TENS which is limiting the market growth.
This research report on the Europe Muscle Stimulation Devices Market has been segmented and sub-segmented into the following categories.
By Product Type:
By End User:
Geographically, Europe holds the second-largest share of the muscle stimulation devices market. However, in the coming years, Europe is anticipated to become one of the largest markets for muscle stimulation devices. Well-established healthcare infrastructure, the availability of Medtech businesses, and favorable reimbursements rules drive regional market growth. In addition, the emerging countries in the region, such as Germany, the UK, Italy, France, and Spain, are expanding the European regional market growth with a significant market share.
The German muscle stimulation devices market held the majority share globally, and it is anticipated to record a claim during the forecast period. Increasing prevalence of chronic pain, raising awareness about muscle stimulator devices, and technological advancements in the healthcare sector boost market growth.
The U.K muscle stimulation devices market is most likely to showcase a significant share in the coming years. The growing geriatric population, increasing prevalence of sports injuries, and growing investments and funding by the government is fueling the market growth.
Emerging countries such as France, Italy, and Spain are projected to witness a good market share during the forecast period. Rising purchasing power, improving the healthcare sector, growing healthcare spending are propelling the market growth.
KEY MARKET PLAYERS
Prominent Companies leading the Europe Muscle Stimulation Devices Market Profiled in the Report are ., Zynex, Inc., NeuroMetrix, Inc, Omron Corp, DJO Global, Inc, RS Medical, Inc.,
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]